MiMedx Group Inc (MDXG)
6.51
+0.13
(+2.04%)
USD |
NASDAQ |
Apr 23, 16:00
6.51
0.00 (0.00%)
After-Hours: 18:47
MiMedx Group Cash from Investing (TTM): -2.155M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.155M |
September 30, 2023 | -3.383M |
June 30, 2023 | -3.108M |
March 31, 2023 | -3.189M |
December 31, 2022 | -2.66M |
September 30, 2022 | -1.265M |
June 30, 2022 | -1.471M |
March 31, 2022 | -1.464M |
December 31, 2021 | -3.395M |
September 30, 2021 | -5.354M |
June 30, 2021 | -5.484M |
March 31, 2021 | -5.548M |
December 31, 2020 | -4.555M |
September 30, 2020 | -3.075M |
June 30, 2020 | -0.305M |
March 31, 2020 | -0.149M |
December 31, 2019 | 0.504M |
September 30, 2019 | 0.111M |
June 30, 2019 | -4.402M |
March 31, 2019 | -6.546M |
December 31, 2018 | -9.22M |
September 30, 2018 | -9.289M |
June 30, 2018 | -8.23M |
March 31, 2018 | -7.535M |
December 31, 2017 | -5.397M |
Date | Value |
---|---|
September 30, 2017 | -5.373M |
June 30, 2017 | -5.713M |
March 31, 2017 | -3.361M |
December 31, 2016 | -11.68M |
September 30, 2016 | -8.855M |
June 30, 2016 | -8.226M |
March 31, 2016 | -8.916M |
December 31, 2015 | -0.678M |
September 30, 2015 | -12.12M |
June 30, 2015 | -11.88M |
March 31, 2015 | -12.57M |
December 31, 2014 | -12.15M |
September 30, 2014 | -2.798M |
June 30, 2014 | -3.064M |
March 31, 2014 | -3.586M |
December 31, 2013 | -3.026M |
September 30, 2013 | -2.770M |
June 30, 2013 | -1.794M |
March 31, 2013 | -0.6637M |
December 31, 2012 | -0.637M |
September 30, 2012 | -0.2201M |
June 30, 2012 | -0.3312M |
March 31, 2012 | -0.321M |
December 31, 2011 | -0.7025M |
September 30, 2011 | -0.8868M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.548M
Minimum
Mar 2021
0.504M
Maximum
Dec 2019
-2.650M
Average
-3.075M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
TELA Bio Inc | -0.599M |
Amylyx Pharmaceuticals Inc | 92.05M |
CEL-SCI Corp | -0.3835M |
AIM ImmunoTech Inc | -0.832M |
IGC Pharma Inc | -0.236M |